Results 91 to 100 of about 1,440 (186)
Ultrastructural changes in dysferlinopathy support defective membrane repair mechanism. [PDF]
Background: The dysferlin gene has recently been shown to be involved in limb girdle muscular dystrophy type 2B and its allelic disease, Miyoshi myopathy, both of which are characterised by an active muscle degeneration and regeneration process ...
CENACCHI, GIOVANNA +7 more
core +1 more source
ABSTRACT Background Skeletal muscle aging is associated with oxidative stress and mitochondrial dysfunction. Peroxiredoxins (PRDXs), particularly PRDX3 and PRDX5, are antioxidant enzymes that are uniquely localized to mitochondria. While PRDX3 has been reported to play a role in maintaining mitochondrial function in muscle, the specific function of ...
Joonho Suh +6 more
wiley +1 more source
Miyoshi myopathy associated with spine rigidity and multiple contractures: a case report
Background Dysferlinopathy is a phenotypically heterogeneous group of hereditary diseases caused by mutations in the DYSF gene. Early contractures are considered rare, and rigid spine syndrome in dysferlinopathy has been previously reported only once ...
Sergey N. Bardakov +11 more
doaj +1 more source
LGMD D3 in Uruguay presents as a slowly progressive adult‐onset scapulo‐pelvic‐peroneal dystrophy. Pathogenic variant c.1132G>C p.(Asp378His) was confirmed in all participants. This is the largest LGMD D3 cluster and first report of sex‐dependent age of onset.
Elisa Demicheli +10 more
wiley +1 more source
Effects of HMG CoA reductase (HMGCR) deficiency on skeletal muscle development
Three skeletal muscle diseases are linked to HMGCR, a key enzyme in cholesterol synthesis. These diseases include a muscular dystrophy associated with pathogenic variants in the HMGCR gene, statin‐associated myopathy, and autoimmune anti‐HMGCR myopathy.
Mekala Gunasekaran +20 more
wiley +1 more source
A case of Miyoshi myopathy in clinical practice
Miyoshi myopathy belongs to the group of dysferlinopathies, rare myopathies, and therefore remains undiagnosed for a long time and currently has no etiopathogenetic treatment.
Nina B. Poletaeva +3 more
doaj +1 more source
Proteomic investigation of the molecular pathophysiology of dysferlinopathy
Abstract Mutations in dysferlin gene cause several types of muscular dystrophy in humans, including the limb‐girdle muscular dystrophy type 2B and the distal muscular dystrophy of Miyoshi. The dysferlin gene product is a membrane‐associated protein belonging to the ferlins family of proteins.
S. De Palma +6 more
openaire +6 more sources
The Role of Repeat Skeletal Muscle Biopsy: Indications, Yield and Outcomes
ABSTRACT Introduction/Aims Muscle biopsy performed to investigate weakness and/or pain may be nondiagnostic and prompt repeat biopsy. We determined the indications and yield of rebiopsy. Methods Patients who underwent > 1 muscle biopsy (South Australia, 2000–2023) were identified.
Thomas Khoo +4 more
wiley +1 more source
Two cases with dysferlinopathy
Dysferlinopathy includes a rare spectrum of muscle disease characterized by two main phenotypes: Miyoshi myopathy(MM) and Limb Girdle muscular dystrophy(LGMD 2B) and results from a mutation of the gene that codes dysferline protein (DYSF gene, 2p13). In this report, we present 2 cases with dysferlinopathy whose diagnosis were confirmed by clinical and ...
Gaye Eryaşar +5 more
openaire +2 more sources
Neuromuscular electrical stimulation (NMES) is integral to studying muscle function in healthy and dystrophic mice. Certain commercial electrodes and laboratory stimulators used for NMES in mice are no longer in production. We developed and/or tested low-
Bana H. Odeh +10 more
doaj +1 more source

